BBGBloomberg·1hBusiness
score+0.60
Bristol-Myers Inks Up to $15 Billion Licensing Deal With Hengrui
Original
Bristol-Myers Inks Up to $15 Billion Licensing Deal With Hengrui
“Business deal framed constructively with emphasis on strategic partnership, significant investment value, and operational efficiency gains.”